Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.

Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2000

Lei Lei, Wang Xiaojia, Chen Zhanhong

Abstract excerpt

Monitoring recurrence and evaluating response to therapy are important aspects of clinical decision making in the treatment of breast cancer. In this literature review, the authors highlight several of the key areas where integrated fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) measurements are anticipated to have a significant impact on monitoring recurrence and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Fluorodeoxyglucose F18

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Metastasis

Share to Neoplasm Recurrence, Local

Share to Positron Emission Tomography Computed Tomography

Share to Predictive Value of Tests

Share to Radiopharmaceuticals

Share to Treatment Outcome

Source

Identifiers

PMID: 27627573
DOI: 10.17219/acem/29853

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PET/CT Imaging for Monitoring Recurrence and Evaluating Response to Treatment in Breast Cancer.PMID 27627573Read ↗

Scoping Review: Emerging (Bio)markers for the Early Detection of Breast Cancer RecurrenceSemantic proximity Read ↗

The diagnostic performance of 18F-FDG PET/CT versus 18F-NaF PET/CT in breast cancer with bone metastases: an indirect comparative meta-analysisSemantic proximity Read ↗

Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy.Semantic proximity Read ↗

Clinical value of hybrid imaging for staging breast cancer in a district general hospitalSemantic proximity Read ↗

FDG-PET/CT and multimodal machine learning model prediction of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancerSemantic proximity Read ↗

Molecular imaging to identify patients with metastatic breast cancer who benefit from endocrine treatment combined with cyclin-dependent kinase inhibitionSemantic proximity Read ↗

Molecular imaging of the breast.Semantic proximity Read ↗

Cone Beam Breast CT in Differentiating Benign Breast Diseases with Different Breast Cancer RisksSemantic proximity Read ↗

Biomarkers of residual disease after neoadjuvant therapy for breast cancer.Semantic proximity Read ↗

PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.Semantic proximity Read ↗

18F-FDG PET/CT-Based Deep Radiomic Models for Enhancing Chemotherapy Response Prediction in Breast CancerSemantic proximity Read ↗

Mid-treatment radiologic response as an early predictor of pathologic response in TNBC in the era of pembrolizumabSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.